Buchumschlag

From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Shiying Zhang, Anli Zhang, Bin Sun
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Chemical Biology & Drug Design
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Pharmacophore‐Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases
von: Chung‐Ting Kuo, et al.
Veröffentlicht: (2026)

Design, Synthesis, Computational Modeling and Biological Evaluation of Novel N‐( 7 H ‐Pyrrolo[2,3‐ d ]pyrimidin‐4‐yl)cinnamamides as Potential Covalent Inhibitors for Oncology
von: Rameshwar S. Cheke, et al.
Veröffentlicht: (2025)

Design and Synthesis of 1,4‐Diformyl‐Piperazine Ferrostatin‐1 Derivatives as Novel Ferroptosis Inhibitors
von: Yi‐Fan Zhang, et al.
Veröffentlicht: (2024)

Tyramine Derivatives as Versatile Pharmacophores With Potent Biological Properties: Sex Hormone–Binding Globulin Inhibition, Colon Cancer Antimigration, and Antimicrobial Activity
von: Jovana S. Marjanović, et al.
Veröffentlicht: (2024)

From Synthesis to Efficacy: Synthesis, Structural Analysis, and Antiviral Activity of 5‐(Trifluoromethoxy)‐ 1 H ‐indole‐2,3‐dione 3‐Thiosemicarbazones
von: Özge Soylu‐Eter, et al.
Veröffentlicht: (2026)

Novel Triazole‐Linked Indole Derivatives as Potent Soluble Epoxy Hydrolase Inhibitors With Promising Anticancer Activity
von: Vijaykumar D. Nimbarte, et al.
Veröffentlicht: (2025)

Design, Docking, ADMET , Pass, Synthesis and Bio‐Evaluation of Novel 7‐ O ‐Substituted Chrysin‐Based VEGFR ‐2 Inhibitors
von: Kalyani R. Thombre, et al.
Veröffentlicht: (2026)

Semisynthetic p‐Coumaric Acid Derivatives as Lead Dual Inhibitors Against DPP‐IV and GSK‐3β for Antidiabetic Therapy
von: Heberth de Paula, et al.
Veröffentlicht: (2024)

Guided Ensemble Stacking Method for Predicting Biological Activities of Compounds
von: Azar Shamloo, et al.
Veröffentlicht: (2025)

Design and Synthesis of Novel MEK Inhibitors for the Treatment of Solid Tumors
von: Jingting Zeng, et al.
Veröffentlicht: (2025)

Mitochondrial Dysfunction Induced by a Novel Salicylate‐Based 1,2,3‐Triazole Salt With Potent Antileishmanial Activity
von: Bruno A. De Oliveira, et al.
Veröffentlicht: (2025)

Chromone Derivatives as a Novel NOX4 Inhibitor: Design, Synthesis, and Regulation of ROS in Renal Fibroblast
von: Siming Wu, et al.
Veröffentlicht: (2024)

Novel Hexahydropyrimidine Derivatives as Potential Neutral Sphingomyelinase 2 Inhibitors: Synthesis, Metal Chelation, and In Silico Studies
von: Ozge Kuyrukcu Ozturk, et al.
Veröffentlicht: (2026)

Integrative Experimental Paradigm of Oxadiazole–Schiff Base Hybrids: Pharmacophore‐Driven Docking Simulations and DFT Insights Toward Antidiabetic Therapeutic Discovery
von: Aisha Bibi, et al.
Veröffentlicht: (2026)

Design, Synthesis, and Evaluation of Bis ‐Chalcones and Bis ‐Flavones as Selective COX ‐2 Inhibitors
von: Rui Pereira, et al.
Veröffentlicht: (2026)

Novel Hydrazide‐Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes
von: Ayşen Işık, et al.
Veröffentlicht: (2024)

Identification of Potent Leucine‐Rich Repeat Kinase 2 Inhibitors by Virtual Screening and Biological Evaluation
von: Hualiang Shen, et al.
Veröffentlicht: (2025)

Machine Learning‐Based Discovery of a Novel Noncovalent MurA Inhibitor as an Antibacterial Agent
von: Qingxin Liu, et al.
Veröffentlicht: (2025)

Synthesis of Novel Soritin Sulfonamide Derivatives as Potential α‐Glucosidase Inhibitor and Their Molecular Docking Studies
von: Nurul Alam Inayatsyah, et al.
Veröffentlicht: (2024)

Design, Hemisynthesis, Characterization, Molecular Docking, and Dynamics Evaluation of Novel Totarol‐1,2,3‐Triazole Derivatives as Leishmaniasis and Toxoplasmosis Agents
von: Ayoub Boualli, et al.
Veröffentlicht: (2025)

Design, Hemisynthesis, Computational, and Biological Evaluation of Novel Totarol‐1,3‐Thiazol Derivatives as Anticancer Agents
von: Ayoub Boualli, et al.
Veröffentlicht: (2026)

Multifaceted In Silico Screening Strategies Identifies Potent Inhibitors Facilitating Inhibition of ZNF726 Activity in Breast Cancer
von: Shreetama Bandyopadhayaya, et al.
Veröffentlicht: (2025)

Comprehensive Analysis of NADH:Ubiquinone Oxidoreductase Subunit B3 in Gynecological Tumors and Identification of Its Natural Inhibitor Wedelolactone
von: Huiping Li, et al.
Veröffentlicht: (2024)

Comment on “Integrative Analysis of Ex Vivo Studies and Microarray Reveals the Novel Inhibitor Effects of Trehalose on the Pathogenesis of Pterygium”
von: Thiago Gonçalves dos Santos Martins
Veröffentlicht: (2024)

Computationally Driven Exploration of Novel bis‐Thiadiazole Sulfonamides as Alzheimer's Enzyme Inhibitors: A DFT and Kinetic Perspective
von: Farman Ullah, et al.
Veröffentlicht: (2025)

Evaluation of Larger Side‐Group Functionalities and the Side/End‐Group Interplay in Ritonavir‐Like Inhibitors of CYP3A4
von: Eric R. Samuels, et al.
Veröffentlicht: (2025)

Molecular Mechanisms and Efficacy of Tislelizumab, a PD ‐1 Inhibitor Developed in China, in Non‐Small Cell Lung Cancer
von: Yihao Liu, et al.
Veröffentlicht: (2026)

Identification of Potential PBP2a Inhibitors Against Methicillin‐Resistant Staphylococcus aureus via Drug Repurposing and Combination Therapy
von: Fangfang Jiao, et al.
Veröffentlicht: (2025)

Brucine alleviates fibroblast‐like synoviocytes dysfunction and inflammation by regulating YY1 during rheumatoid arthritis
von: Qian Zhang, et al.
Veröffentlicht: (2024)

Forsythiaside A Ameliorates Oxidative Damage Caused by Cerebral Ischemia Through the Nrf2/HO‐1 Signaling Pathway
von: Wei Li, et al.
Veröffentlicht: (2025)

Novel Synthesized Benzophenone Thiazole Hybrids Exhibited Ex Vivo and In Silico Anti‐Inflammatory Activity
von: Luiz Paulo Melchior de Oliveira Leão, et al.
Veröffentlicht: (2024)

Protein Kinase Inhibitors: Synthesis and Molecular Repurposing in Three‐Dimensional Cancer Models PKI
von: Vladislav Lobanov, et al.
Veröffentlicht: (2025)

Synthesis and Molecular Modeling Studies of New Thiadiazole‐Thiophene Compounds as Potent Antimicrobial Agents
von: Nuha M. Halawani, et al.
Veröffentlicht: (2025)

Computationally Guided Structural Modification of Centaureidin: A Novel Approach for Enhancing Antioxidant and Antitumor Activities for Drug Development
von: Reem S. Alruhaimi, et al.
Veröffentlicht: (2025)

Small Molecule Inhibitors Targeting Cdc2‐Like Kinase 4: Advances, Challenges, and Opportunities
von: Yu Jiang, et al.
Veröffentlicht: (2025)

Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease
von: Gözde Sayar, et al.
Veröffentlicht: (2026)

A Comprehensive Review on the Advancements of Dual COX‐2/5‐LOX Inhibitors as Anti‐Inflammatory Drugs
von: Neetu Agrawal
Veröffentlicht: (2025)

Structure‐Based Design of 2‐Aminopyrazolpyrimidopyridone Derivatives as New Rearranged During Transfection (RET) Kinase Inhibitors
von: Jiayi Shen, et al.
Veröffentlicht: (2024)

Synthesis and Antitumor Evaluation of a Novel Class of Chalcone Mannich Base Derivatives
von: Bing He, et al.
Veröffentlicht: (2025)

Network Pharmacology and Transcriptomic Analysis Reveal the Mechanism by Which Ginsenoside CK Remodels the Tumor Immune Microenvironment to Inhibit Liver Cancer Progression
von: Fangzhi Ye, et al.
Veröffentlicht: (2025)